Real-world data on Pfizer and Oxford COVID vaccines stunningly good
Professor Andrew Pollard, director of the Oxford Vaccine Group, welcomed the new study from Public Health England (PHE) which found that protection against developing symptomatic Covid-19 in the over-70s was around 60% for both Oxford and Pfizer after a single dose, while among the over-80s the vaccines offered more than 80% protection against hospital admission.
Prof Pollard told BBC Radio 4’s Today programme the findings were “stunning”, and this was for two reasons.
“First of all, because these data come from the hardest group to protect – those who are the frailest, the oldest adults in our population – and we’re seeing an 80% reduction in hospitalisation in that group, which is stunning,” he said.
“Second… both of the vaccines performed exactly the same, there was no daylight between them.
“We’ve had all this difficulty with communication, particularly around Europe, with uncertainty about the evidence, whereas in the UK we’ve been rolling out both vaccines in the confidence that they would both give high levels of protection.
“And that’s absolutely what we’ve seen now in this real-world evidence – that whether you’ve had a Pfizer vaccine or the Oxford AstraZeneca vaccine, you have very high levels of protection. ■